Angaut-Petit D, Juzans P, Molgó J, Faille L, Seagar M J, Takahashi M, Shoji-Kasai Y
Laboratoire de Neurobiologie Cellulaire et Moléculaire, CNRS, Gif-sur-Yvette, France.
Brain Res. 1995 May 29;681(1-2):213-7. doi: 10.1016/0006-8993(95)00294-z.
An antibody directed against the lumenal NH2-terminus of synaptotagmin II was used to examine the distribution of this vesicular protein either after spontaneous acetylcholine release or after sustained release induced by La3+ or alpha-latrotoxin, in conditions that prevent endocytosis. The detection of the epitope was examined in the presence or absence of Triton X-100. We show that, in resting conditions of transmitter release, permeabilization of nerve terminal membranes is required for obvious detection of synaptotagmin Ii immunoreactivity whereas during sustained rates of quantal release, permeabilization is not necessary. These data indicate that, in the latter conditions, synaptotagmin II is incorporated into the terminal axolemma and its intravesicular domain exposed at the extracellular nerve terminal surface.
一种针对突触结合蛋白II腔内NH2末端的抗体,用于在防止内吞作用的条件下,检测这种囊泡蛋白在自发乙酰胆碱释放后,或在La3+或α- latrotoxin诱导的持续释放后的分布。在存在或不存在Triton X-100的情况下检测表位。我们发现,在递质释放的静息条件下,神经末梢膜的通透化是明显检测突触结合蛋白Ii免疫反应性所必需的,而在持续的量子释放速率期间,通透化则不是必需的。这些数据表明,在后一种情况下,突触结合蛋白II被整合到终末轴膜中,其囊泡内结构域暴露于细胞外神经末梢表面。